Estate Planners Group’s Ginkgo Bioworks DNA Stock Holding History

Estate Planners Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$17	–	155
2025 Q4	$17	Buy	+2	New	+$22	﹤0.01%	465

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Estate Planners Group's DNA Position: Q1 2026 in Review

Estate Planners Group sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 2 shares — an estimated $17 sold.

Estate Planners Group first reported a position in DNA in Q4 2025 and held it in 1 quarter. The position peaked at $17 in Q4 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Estate Planners Group reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
Estate Planners Group sold 2 Ginkgo Bioworks shares in Q1 2026, an estimated $17.
Estate Planners Group first reported a position in Ginkgo Bioworks in Q4 2025 and held it in 1 quarter.
Estate Planners Group's Ginkgo Bioworks position peaked at $17 in Q4 2025.
175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.